Want to see LKFT full AI Analyst Report?
ETFs with Lakefront Biotherapeutics (LKFT) Exposure
The following ETFs maintain exposure to Lakefront Biotherapeutics (LKFT). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
17 ETFs Hold Lakefront Biotherapeutics (LKFT)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in LKFT |
|---|---|---|---|---|---|---|
| SBIO | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | 1.43% | $2.63M | 0.12% |
| QQQS | Invesco NASDAQ Future Gen 200 ETF | $21.73M | 0.20% | 0.64% | $133.32K | <0.01% |
| CURE | VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD | $25.71M | 0.35% | 0.33% | $84.35K | <0.01% |
| ZINN | ― | ― | ― | 0.14% | $13.18K | <0.01% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 0.10% | $10.96M | 0.52% |
| AVDS | Avantis International Small Cap Equity ETF | $379.08M | 0.30% | 0.07% | $245.87K | 0.01% |
| APIE | ActivePassive International Equity ETF | $1.13B | 0.45% | 0.05% | $509.78K | 0.02% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.03% | $38.54K | <0.01% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.03% | $403.45K | 0.02% |
| DDXM | Dimensional Funds ICAV - Dimensional Global ex US Core Equity Market UCITS ETF USD Acc | ― | 0.22% | <0.01% | $13.20K | <0.01% |
| CADE | Avantis CIBC International Equity ETF Common Units Trust Units | $351.25M | ― | <0.01% | $24.92K | <0.01% |
| AVDE | Avantis International Equity ETF | $19.65B | 0.23% | <0.01% | $1.19M | 0.06% |
| AVEU | American Century ICAV - Avantis Europe Equity Ucits Etf | $39.57M | 0.26% | <0.01% | $1,616.5 | <0.01% |
| AVGC | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | <0.01% | $18.40K | <0.01% |
| AVUS | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | <0.01% | $18.40K | <0.01% |
| DDGC | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | <0.01% | $35.42K | <0.01% |
| DDGT | Dimensional Funds ICAV - Global Targeted Value UCITS ETF Accum Shs USD | ― | 0.47% | <0.01% | $1,648.83 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in LKFT |
|---|---|---|---|---|---|---|
| SBIO | 1.43% | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | $2.63M | 0.12% |
| QQQS | 0.64% | Invesco NASDAQ Future Gen 200 ETF | $21.73M | 0.20% | $133.32K | <0.01% |
| CURE | 0.33% | VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD | $25.71M | 0.35% | $84.35K | <0.01% |
| ZINN | 0.14% | ― | ― | ― | $13.18K | <0.01% |
| IBB | 0.10% | iShares Biotechnology ETF | $11.52B | 0.44% | $10.96M | 0.52% |
| AVDS | 0.07% | Avantis International Small Cap Equity ETF | $379.08M | 0.30% | $245.87K | 0.01% |
| APIE | 0.05% | ActivePassive International Equity ETF | $1.13B | 0.45% | $509.78K | 0.02% |
| IBBQ | 0.03% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $38.54K | <0.01% |
| OM3E | 0.03% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $403.45K | 0.02% |
| DDXM | <0.01% | Dimensional Funds ICAV - Dimensional Global ex US Core Equity Market UCITS ETF USD Acc | ― | 0.22% | $13.20K | <0.01% |
| CADE | <0.01% | Avantis CIBC International Equity ETF Common Units Trust Units | $351.25M | ― | $24.92K | <0.01% |
| AVDE | <0.01% | Avantis International Equity ETF | $19.65B | 0.23% | $1.19M | 0.06% |
| AVEU | <0.01% | American Century ICAV - Avantis Europe Equity Ucits Etf | $39.57M | 0.26% | $1,616.5 | <0.01% |
| AVGC | <0.01% | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | $18.40K | <0.01% |
| AVUS | <0.01% | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | $18.40K | <0.01% |
| DDGC | <0.01% | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | $35.42K | <0.01% |
| DDGT | <0.01% | Dimensional Funds ICAV - Global Targeted Value UCITS ETF Accum Shs USD | ― | 0.47% | $1,648.83 | <0.01% |
Popular ETF Comparisons
LKFT ETF Exposure FAQ
What ETFs hold Lakefront Biotherapeutics stock?
Lakefront Biotherapeutics (LKFT) is currently held by 17 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to LKFT include iShares (IBB), ALPS (SBIO) and ActivePassive (APIE).
Which ETF has the largest exposure to LKFT?
The ETF with the largest exposure to LKFT is iShares (IBB), with approximately $10.96M in market value exposure.
How much LKFT stock is held by ETFs?
ETFs currently hold approximately $15.03M worth of Lakefront Biotherapeutics (LKFT) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.